Valerio Therapeutics S.A.
ALVIO.PA · PAR
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | €11,541 | €22,378 | €28,551 | €23,817 |
| - Cash | €1,178 | €6,818 | €14,586 | €17,887 |
| + Debt | €13,435 | €8,998 | €10,088 | €9,935 |
| Enterprise Value | €23,798 | €24,558 | €24,053 | €15,865 |
| Revenue | €1,793 | €1,800 | €1,443 | €4,062 |
| % Growth | -0.4% | 24.7% | -64.5% | – |
| Gross Profit | €1,280 | €1,267 | €929 | €3,694 |
| % Margin | 71.4% | 70.4% | 64.4% | 90.9% |
| EBITDA | -€12,062 | -€18,444 | -€17,037 | -€5,857 |
| % Margin | -672.7% | -1,024.7% | -1,180.7% | -144.2% |
| Net Income | -€23,931 | -€20,344 | -€19,562 | -€5,937 |
| % Margin | -1,334.7% | -1,130.2% | -1,355.6% | -146.2% |
| EPS Diluted | -0.16 | -0.15 | -0.18 | -0.067 |
| % Growth | -6.7% | 16.7% | -167.5% | – |
| Operating Cash Flow | -€12,460 | -€18,597 | -€9,443 | -€8,572 |
| Capital Expenditures | -€319 | -€183 | -€488 | -€139 |
| Free Cash Flow | -€12,779 | -€18,780 | -€9,931 | -€8,711 |